vs
Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and Metallus Inc. (MTUS). Click either name above to swap in a different company.
HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $267.3M, roughly 1.0× Metallus Inc.). HUTCHMED (China) Ltd runs the higher net margin — 0.7% vs -5.3%, a 6.1% gap on every dollar of revenue. On growth, Metallus Inc. posted the faster year-over-year revenue change (11.1% vs -16.5%). HUTCHMED (China) Ltd produced more free cash flow last quarter ($3.4M vs $-37.2M).
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
HCM vs MTUS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $270.8M | $267.3M |
| Net Profit | $2.0M | $-14.3M |
| Gross Margin | 37.7% | 2.2% |
| Operating Margin | -13.2% | -7.7% |
| Net Margin | 0.7% | -5.3% |
| Revenue YoY | -16.5% | 11.1% |
| Net Profit YoY | -83.6% | 33.2% |
| EPS (diluted) | $0.00 | $-0.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.8M | $267.3M | ||
| Q3 25 | — | $305.9M | ||
| Q2 25 | $277.7M | $304.6M | ||
| Q1 25 | $324.5M | $280.5M | ||
| Q4 24 | — | $240.5M | ||
| Q3 24 | — | $227.2M | ||
| Q2 24 | $305.7M | $294.7M | ||
| Q1 24 | — | $321.6M |
| Q4 25 | $2.0M | $-14.3M | ||
| Q3 25 | — | $8.1M | ||
| Q2 25 | $455.0M | $3.7M | ||
| Q1 25 | $11.9M | $1.3M | ||
| Q4 24 | — | $-21.4M | ||
| Q3 24 | — | $-5.9M | ||
| Q2 24 | $25.8M | $4.6M | ||
| Q1 24 | — | $24.0M |
| Q4 25 | 37.7% | 2.2% | ||
| Q3 25 | — | 11.4% | ||
| Q2 25 | 0.1% | 10.6% | ||
| Q1 25 | 48.0% | 7.8% | ||
| Q4 24 | — | 4.5% | ||
| Q3 24 | — | 5.3% | ||
| Q2 24 | 41.1% | 8.2% | ||
| Q1 24 | — | 15.7% |
| Q4 25 | -13.2% | -7.7% | ||
| Q3 25 | — | 3.6% | ||
| Q2 25 | -1.3% | 2.8% | ||
| Q1 25 | -5.0% | 1.0% | ||
| Q4 24 | — | -10.1% | ||
| Q3 24 | — | -3.1% | ||
| Q2 24 | -9.0% | 2.1% | ||
| Q1 24 | — | 9.3% |
| Q4 25 | 0.7% | -5.3% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | 163.8% | 1.2% | ||
| Q1 25 | 3.7% | 0.5% | ||
| Q4 24 | — | -8.9% | ||
| Q3 24 | — | -2.6% | ||
| Q2 24 | 8.4% | 1.6% | ||
| Q1 24 | — | 7.5% |
| Q4 25 | $0.00 | $-0.34 | ||
| Q3 25 | — | $0.19 | ||
| Q2 25 | $0.52 | $0.09 | ||
| Q1 25 | $0.01 | $0.03 | ||
| Q4 24 | — | $-0.46 | ||
| Q3 24 | — | $-0.13 | ||
| Q2 24 | $0.03 | $0.10 | ||
| Q1 24 | — | $0.52 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $156.7M |
| Total DebtLower is stronger | $93.2M | — |
| Stockholders' EquityBook value | $1.2B | $686.0M |
| Total Assets | $1.8B | $1.1B |
| Debt / EquityLower = less leverage | 0.08× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4B | $156.7M | ||
| Q3 25 | — | $191.5M | ||
| Q2 25 | $1.4B | $190.8M | ||
| Q1 25 | $836.1M | $180.3M | ||
| Q4 24 | — | $240.7M | ||
| Q3 24 | — | $254.6M | ||
| Q2 24 | $802.5M | $272.8M | ||
| Q1 24 | — | $278.1M |
| Q4 25 | $93.2M | — | ||
| Q3 25 | — | $0 | ||
| Q2 25 | $93.4M | $0 | ||
| Q1 25 | $82.8M | $5.4M | ||
| Q4 24 | — | $5.4M | ||
| Q3 24 | — | $13.2M | ||
| Q2 24 | $82.1M | $13.2M | ||
| Q1 24 | — | $13.2M |
| Q4 25 | $1.2B | $686.0M | ||
| Q3 25 | — | $697.7M | ||
| Q2 25 | $1.2B | $690.0M | ||
| Q1 25 | $759.9M | $686.1M | ||
| Q4 24 | — | $690.5M | ||
| Q3 24 | — | $712.7M | ||
| Q2 24 | $740.1M | $736.3M | ||
| Q1 24 | — | $739.3M |
| Q4 25 | $1.8B | $1.1B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | $1.8B | $1.1B | ||
| Q1 25 | $1.3B | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | $1.3B | $1.1B | ||
| Q1 24 | — | $1.2B |
| Q4 25 | 0.08× | — | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | 0.08× | 0.00× | ||
| Q1 25 | 0.11× | 0.01× | ||
| Q4 24 | — | 0.01× | ||
| Q3 24 | — | 0.02× | ||
| Q2 24 | 0.11× | 0.02× | ||
| Q1 24 | — | 0.02× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | $-1.9M |
| Free Cash FlowOCF − Capex | $3.4M | $-37.2M |
| FCF MarginFCF / Revenue | 1.2% | -13.9% |
| Capex IntensityCapex / Revenue | 1.8% | 13.2% |
| Cash ConversionOCF / Net Profit | 4.21× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-96.2M | $-93.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | $-1.9M | ||
| Q3 25 | — | $22.0M | ||
| Q2 25 | $-72.9M | $34.8M | ||
| Q1 25 | $40.3M | $-38.9M | ||
| Q4 24 | — | $13.9M | ||
| Q3 24 | — | $-15.3M | ||
| Q2 24 | $-39.8M | $8.3M | ||
| Q1 24 | — | $33.4M |
| Q4 25 | $3.4M | $-37.2M | ||
| Q3 25 | — | $-6.4M | ||
| Q2 25 | $-82.2M | $17.0M | ||
| Q1 25 | $32.5M | $-66.4M | ||
| Q4 24 | — | $-1.3M | ||
| Q3 24 | — | $-32.9M | ||
| Q2 24 | $-49.9M | $-5.8M | ||
| Q1 24 | — | $16.0M |
| Q4 25 | 1.2% | -13.9% | ||
| Q3 25 | — | -2.1% | ||
| Q2 25 | -29.6% | 5.6% | ||
| Q1 25 | 10.0% | -23.7% | ||
| Q4 24 | — | -0.5% | ||
| Q3 24 | — | -14.5% | ||
| Q2 24 | -16.3% | -2.0% | ||
| Q1 24 | — | 5.0% |
| Q4 25 | 1.8% | 13.2% | ||
| Q3 25 | — | 9.3% | ||
| Q2 25 | 3.3% | 5.8% | ||
| Q1 25 | 2.4% | 9.8% | ||
| Q4 24 | — | 6.3% | ||
| Q3 24 | — | 7.7% | ||
| Q2 24 | 3.3% | 4.8% | ||
| Q1 24 | — | 5.4% |
| Q4 25 | 4.21× | — | ||
| Q3 25 | — | 2.72× | ||
| Q2 25 | -0.16× | 9.41× | ||
| Q1 25 | 3.38× | -29.92× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.54× | 1.80× | ||
| Q1 24 | — | 1.39× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HCM
Segment breakdown not available.
MTUS
| Industrial Market Sector | $95.3M | 36% |
| Manufactured Components | $67.8M | 25% |
| Aerospace And Defense | $39.6M | 15% |
| Seamless Mechanical Tubing | $31.3M | 12% |
| Energy Market Sector | $18.3M | 7% |
| Other | $11.3M | 4% |
| Other Market Sector | $3.7M | 1% |